Biotrack Biology: Net loss of 10.2079 million yuan in the first quarter of 2026.

Botao Biology announces that the operating income in the first quarter of 2026 was 89.37 million yuan, an increase of 1.70% year-on-year. The net loss attributable to the shareholders of the listed company was 10.21 million yuan, compared to a net profit of 8.73 million yuan in the same period of the previous year.